Clinical Trial Update: A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating LDE225 (sonidegib) as a pre-surgical treatment in men with high-risk localized prostate cancer; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• LDE225 (sonidegib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-03-07